Literature DB >> 19779496

p27(BBP)/eIF6 acts as an anti-apoptotic factor upstream of Bcl-2 during Xenopus laevis development.

N De Marco1, L Iannone, R Carotenuto, S Biffo, A Vitale, C Campanella.   

Abstract

p27(BBP)/eIF6 (beta4-binding protein/eukaryotic initiation factor 6) regulates the joining of 40S and 60S ribosomal subunits, on receptor for activated C kinase 1 binding and protein kinase C phosphorylation in serine 235. In Xenopus, p27(BBP)/eIF6 is abundantly expressed in the majority of the embryonic anlagen. Although p27(BBP)/eIF6 abundance may be required for a general regulation of protein synthesis, our data suggest that p27(BBP)/eIF6 may target the translation of specific mRNAs. We injected Xp27(BBP)/eIF6 mRNA in one blastomere of two-cell-stage embryos and obtained a bent phenotype, the curvature being lateral with respect to the embryo antero-posterior axis. The injected side had fewer apoptotic cells than the uninjected side, whereas cell proliferation appeared unaffected. Accordingly, in Xp27(BBP)/eIF6 morphants, endogenous apoptosis increased. Injection of Xp27(BBP)/eIF6 point mutants indicated that the anti-apoptotic action of Xp27(BBP)/eIF6 requires the conserved S235. The bent phenotype was also obtained with B-cell lymphoma gene-2 (Bcl-2) overexpression and was rescued by Bcl-2-associated X protein (Bax)/Xp27(BBP)/eIF6 co-injection. In addition, embryos overexpressing Xp27(BBP)/eIF6 had a higher amount of Bcl-2 and an unchanged amount of Bax with respect to controls. In Xp27(BBP)/eIF6 morphants, Bcl-2 levels were unaffected and Bax levels were higher than in the controls. Thus, we propose that Xp27(BBP)/eIF6 is part of a mechanism acting on the specific translation of messengers regulating cell survival. In particular, we suggest that Xp27(BBP)/eIF6 may regulate the translation of factors upstream of Bcl-2/Bax.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779496     DOI: 10.1038/cdd.2009.128

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  7 in total

1.  Anti-apoptotic activity and proteasome-mediated degradation of Xenopus Mcl-1 protein in egg extracts.

Authors:  Yuichi Tsuchiya; Shigeru Yamashita
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

2.  The biological roles of ITGB4BP and its potential effect on fibrosis.

Authors:  Jianglin Tan; Gaoxing Luo; Jun Wu
Journal:  Int J Burns Trauma       Date:  2011-09-02

3.  The translation factor eIF6 is a Notch-dependent regulator of cell migration and invasion.

Authors:  Dario Benelli; Samantha Cialfi; Michela Pinzaglia; Claudio Talora; Paola Londei
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

4.  Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.

Authors:  Nicole Golob-Schwarzl; Caroline Schweiger; Carina Koller; Stefanie Krassnig; Margit Gogg-Kamerer; Nadine Gantenbein; Anna M Toeglhofer; Christina Wodlej; Helmut Bergler; Brigitte Pertschy; Stefan Uranitsch; Magdalena Holter; Amin El-Heliebi; Julia Fuchs; Andreas Punschart; Philipp Stiegler; Marlen Keil; Jens Hoffmann; David Henderson; Hans Lehrach; Christoph Reinhard; Christian Regenbrecht; Rudolf Schicho; Peter Fickert; Sigurd Lax; Johannes Haybaeck
Journal:  Oncotarget       Date:  2017-09-05

5.  The role of eukaryotic translation initiation factor 6 in tumors.

Authors:  Wei Zhu; Gui Xian Li; Hong Lang Chen; Xing Yan Liu
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

6.  Protective Effects of Scutellarin on Human Cardiac Microvascular Endothelial Cells against Hypoxia-Reoxygenation Injury and Its Possible Target-Related Proteins.

Authors:  Meina Shi; Yingting Liu; Lixing Feng; Yingbo Cui; Yajuan Chen; Peng Wang; Wenjuan Wu; Chen Chen; Xuan Liu; Weimin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-18       Impact factor: 2.629

7.  Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.

Authors:  Zhikui Liu; Huanye Mo; Liankang Sun; Liang Wang; Tianxiang Chen; Bowen Yao; Runkun Liu; Yongshen Niu; Kangsheng Tu; Qiuran Xu; Nan Yang
Journal:  Cancer Sci       Date:  2020-09-23       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.